Mathias Hukkelhoven - 01 Jul 2022 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Director
Signature
/s/ Marella Thorell, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
01 Jul 2022
Net transactions value
$0
Form type
4
Filing time
06 Jul 2022, 18:15:12 UTC
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTA Share Option (right to buy) Award $0 +96,000 $0.000000 96,000 01 Jul 2022 Ordinary Shares 96,000 $5.17 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to such option will vest in 36 equal monthly installments over three years from the grant date, subject to continued service as a director through the applicable vesting date.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.